Foyston, Gordon, & Payne Inc Viatris Inc Transaction History
Foyston, Gordon, & Payne Inc
- $400 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,101Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.46 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$963 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$648 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$597 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$593 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...